Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

RNA THERAPEUTICS

RNA delivery with a human virus-like particle

RNA cargo is transferred into cultured cells using a fully human delivery system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Delivery of mRNA cargo by virus-like particles derived from endogenous retroelements.

References

  1. Segel, M. et al. Science 373, 882–889 (2021).

    Article  CAS  Google Scholar 

  2. Feschotte, C. & Gilbert, C. Nat. Rev. Genet. 13, 283–296 (2012).

    Article  CAS  Google Scholar 

  3. Ono, R. et al. Nat. Genet. 38, 101–106 (2006).

    Article  CAS  Google Scholar 

  4. Baden, L. R. et al. N. Engl. J. Med. 384, 403–416 (2021).

    Article  CAS  Google Scholar 

  5. Polack, F. P. et al. N. Engl. J. Med. 383, 2603–2615 (2020).

    Article  CAS  Google Scholar 

  6. Rosenblum, D., Gutkin, A., Dammes, N. & Peer, D. Adv. Drug Deliv. Rev. 154-155, 176–186 (2020).

    Article  CAS  Google Scholar 

  7. Kedmi, R. et al. Nat. Nanotechnol. 13, 214–219 (2018).

    Article  CAS  Google Scholar 

  8. Veiga, N. et al. J. Control. Release 313, 33–41 (2019).

    Article  CAS  Google Scholar 

  9. Rosenblum, D. et al. Sci. Adv. 6, eabc9450 (2020).

    Article  CAS  Google Scholar 

  10. Dammes, N. et al. Nat. Nanotechnol. 16, 1030–1038 (2021).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dan Peer.

Ethics declarations

Competing interests

D.P. receives licensing fees (to patents on which he was an inventor) from, invested in, consults (or on scientific advisory boards or boards of directors) for, lectured (and received a fee) or conducts sponsored research at TAU for the following entities: ART Biosciences, BioNTech RNA Pharmaceuticals, EPM Inc., Earli Inc., lmpetis Biosciences, Kernal Biologics, Newphase Ltd, NLC Pharma Ltd, NeoVac Ltd, Roche, SirTLabs Corporation and Teva Pharmaceuticals Inc. All other authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gutkin, A., Rosenblum, D. & Peer, D. RNA delivery with a human virus-like particle. Nat Biotechnol 39, 1514–1515 (2021). https://doi.org/10.1038/s41587-021-01124-x

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41587-021-01124-x

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research